On September 16, 2021, Cisema will be participating in Business Finland’s 2021 China Health Tech Series III to cover the following topics in the coaching session:
- NMPA registration of medical devices, and IVDs
- Software and its regulatory implications in China (SaMDs and SiMDs)
- Regulatory hurdles
- Regulatory updates & post-market surveillance
- Alternative pathways
Background
The Chinese medical device industry is large and has good potential. In 2019, the industry was worth RMB 629 billion doubling its size in 2015. In 2020, due to strong demand for Covid-19 related medical devices, the industry’s value went up to RMB 800 billion. Overall, China’s medical device industry has been growing at a rate of 20% since 2015 and it now accounts for about 20% of the global medical device market share. Therefore it is a crucial market for Finnish health tech companies to consider.
Agenda
10:00 – 10:05: Opening remarks by Business Finland
10:05 – 11:05: Coaching Session – “NMPA Registration of Medical Devices, IVDs, and software in China” by Cisema)
11:05 – 11:30: Q&A
Who should attend?
Finnish health tech companies with interests in China.
Registration link: TBA
Contact Cisema if you would like to learn more.
